|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 264, Issue 4 E638-E643, Copyright © 1993 by American Physiological Society
ARTICLES |
H. D. McCarthy, P. E. McKibbin, A. V. Perkins, E. A. Linton and G. Williams
Department of Medicine, University of Liverpool, United Kingdom.
Regional hypothalamic concentrations of neuropeptide Y (NPY) and corticotropin-releasing factor (CRF), respectively a stimulant and an inhibitor of feeding behavior, were investigated in hypothalamic nuclei in rats carrying the Yoshida sarcoma. Tumor-bearing rats (n = 10), non-tumor-bearing controls (n = 10), and food-restricted rats (n = 10), which did not carry tumors but were pair-fed to match the reduced food intake of the tumor-bearing group, were studied after 10 days. NPY concentrations in the arcuate nucleus (ARC, the main site of NPY synthesis) were significantly increased above controls (P < 0.01) in both tumor-bearing and food-restricted groups. However, NPY concentrations in the paraventricular nucleus (PVN, an NPY-sensitive site of NPY release) showed opposing changes, with a 25% decrease (P = 0.052) in the tumor-bearing but a 48% increase (P < 0.01) in the food-restricted group. CRF concentrations in both the PVN and the ARC were significantly reduced (P < 0.01) in the food-restricted group, but remained close to control values in the tumor-bearing group (P not significant). Changes in hypothalamic appetite-regulating neuropeptides in cancer anorexia, which may result from the action of cytokines produced by a host defense response or the tumor itself, may account for reduced feeding. Such changes may include impaired activity of NPY or failure of CRF activity to be suppressed after underfeeding and weight loss.
This article has been cited by other articles:
![]() |
A. Inui Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key? Cancer Res., September 1, 1999; 59(18): 4493 - 4501. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stricker-Krongrad, R. Kozak, C. Burlet, J. P. Nicolas, and B. Beck Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2112 - R2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Raber, S. Chen, L. Mucke, and L. Feng Corticotropin-releasing Factor and Adrenocorticotrophic Hormone as Potential Central Mediators of OB Effects J. Biol. Chem., June 13, 1997; 272(24): 15057 - 15060. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Heinrichs, J. Lapsansky, D. P. Behan, R. K. W. Chan, P. E. Sawchenko, M. Lorang, N. Ling, W. W. Vale, and E. B. De Souza Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal PNAS, December 24, 1996; 93(26): 15475 - 15480. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |